JPRN-UMIN000009246已完成未知
Superiority of bixalomer (Kiklin) as phosphate binder and impact on lipid metabolism in HD patients (Skip-study) - Superiority of bixalomer (Kiklin) as phosphate binder and impact on lipid metabolism in HD patients (Skip-study)
Juntendo University Faculty of Medicine0 个研究点目标入组 30 人开始时间: 2012年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients are excluded if they are compatible with any one of the following criteria. 1,Patients with a history of hypersensitivity for an ingredient of this medicine 2,Patients with bowel obstruction (for a non-absorbable polymer, we might raise intestinal perforation) 3,Patients with significant psychic disturbance or drug dependence disease or alcoholism 4,Patients that going to hospital of all follow-up seems to be impossible 5,Patients who are not able to understand a test instructions from medical experts of the client side or the doctors involved in the study 6,Patients who judged as inadequate by the doctors involved in the study
研究者
相似试验
进行中（未招募）
1 期
Comparison of two substitution fluids (Biphozyl® and Phoxilium® ) during continuous renal replacement therapy in adult critically ill patients with acute kidney injury and their effects on acid-base status and respiratory situation. – A prospective, randomized, controlled, open, cross-over, Phase II, single-center pilot studyAcute Kidney Injury (AKI). This is a A prospective, randomized, controlled, open, cross-over, Phase II, single-center pilot study to assess the effects of two different continuous veno-venous hemofiltration (CVVH) replacement fluids (Phoxilium® and Biphozyl®) in adult critically ill AKI patients treated with CVVH. Anticoagulation is delivered as pre-filter regional citrate anticoagulation with Regiocit® (Gambro Lundia AB, Sweden).EUCTR2019-001262-15-ATMedical University Innsbruck88
已完成
不适用
Comparision of bixalomer (Kiklin) dose timing as phosphate binder and impact in HD patientsHemodialysis patients with hyperphosphatemiaJPRN-UMIN000009792Juntendo University Hospital30
已完成
不适用
Efficacy and tolerability of bixalomer for treatment of hyperphosphatemia in maintenance hemodialysis patients with poor tolerance to sevelamer: a switching study.Chronic renal failureJPRN-UMIN000010671Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic50
招募中
不适用
Evaluation of Usefulness of Bisphosphanate for diffuse sclerosing osteomyelitis of the jawDiffuse Sclerosing Osteomyelitis of the jawJPRN-UMIN000032089Hokkaido University13
已完成
2 期
Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.Prediabetes.Impaired glucose tolerance, Menopausal and other perimenopausal disorders, Postmenopausal osteoporosisR73, N95,IRCT2016101530309N1Vice chancellor for research, Isfahan University of Medical Sciences60